NCT04712175View on ClinicalTrials.gov

Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 18, 2023

Conditions

Covid19

Interventions

DIAGNOSTIC_TEST

Nasopharyngeal sampling

Swabs will be taken of nasopharyngeal samples for RT-PCR

DIAGNOSTIC_TEST

Saliva sampling

A 10ml saliva sample will collected in a sterile 60ml bottle for mass spectrometry and RT-PCR

Trial Locations (1)

Unknown

CHU de Nîmes, Nîmes

All Listed Sponsors

collaborator

Technological Innovations for Detection and Diagnosis Laboratory

UNKNOWN

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT04712175 - Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry | Biotech Hunter | Biotech Hunter